mRNA vaccine
E523135
An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
All labels observed (2)
| Label | Occurrences |
|---|---|
| MRNA | 1 |
| mRNA vaccine canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5481690 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: mRNA vaccine Context triple: [COVID-19 vaccines, hasType, mRNA vaccine]
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
COVID-19 vaccines
COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: mRNA vaccine Target entity description: An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
-
A.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
-
B.
COVID-19 vaccines
COVID-19 vaccines are immunizations developed to protect against the SARS-CoV-2 virus, significantly reducing the risk of severe illness, hospitalization, and death from COVID-19.
-
C.
Janssen COVID-19 Vaccine
The Janssen COVID-19 Vaccine is a single-dose, viral vector-based coronavirus vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for the prevention of COVID-19.
-
D.
Moderna
Moderna is a biotechnology company best known for pioneering mRNA-based vaccines, including one of the first widely used COVID-19 vaccines.
-
E.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biological product
ⓘ
medical technology ⓘ vaccine type ⓘ |
| canBe |
monovalent
ⓘ
multivalent ⓘ |
| canBeFormulatedAs |
modRNA vaccine
ⓘ
self-amplifying mRNA vaccine ⓘ |
| canTarget |
Zika virus
NERFINISHED
ⓘ
cancer neoantigens ⓘ cytomegalovirus NERFINISHED ⓘ influenza virus ⓘ rabies virus ⓘ respiratory syncytial virus NERFINISHED ⓘ |
| doesNotContain | live virus ⓘ |
| doesNotIntegrateInto | host DNA ⓘ |
| encodes | viral protein ⓘ |
| hasAdvantage |
flexible antigen design
ⓘ
no need to grow pathogen in culture ⓘ potential for quick updates against variants ⓘ rapid design and development ⓘ |
| hasComponent |
3′ untranslated region
ⓘ
5′ cap structure ⓘ 5′ untranslated region ⓘ lipid nanoparticle excipients ⓘ nucleoside-modified mRNA ⓘ poly(A) tail ⓘ |
| hasMechanism | instructs host cells to produce antigen ⓘ |
| hasSafetyProfile | generally transient local and systemic reactions ⓘ |
| induces | immune response ⓘ |
| isDeliveredBy | injection ⓘ |
| isDeliveredWith | lipid nanoparticles ⓘ |
| isRegulatedAs | biological medicinal product ⓘ |
| isSubjectOf | intense clinical research ⓘ |
| isTranscribedIn | cell cytoplasm ⓘ |
| isTranslatedBy | host ribosomes ⓘ |
| isUsedIn | mass immunization campaigns ⓘ |
| mayRequire |
booster doses
ⓘ
prime-boost schedule ⓘ |
| produces | antigenic protein in host cells ⓘ |
| requires | cold chain storage ⓘ |
| stimulates |
B cell response
ⓘ
T cell response ⓘ antibody production ⓘ cell-mediated immunity ⓘ |
| targets |
SARS-CoV-2
NERFINISHED
ⓘ
infectious diseases ⓘ |
| usesMolecule | messenger RNA ⓘ |
| wasPioneeredIn | early 1990s ⓘ |
| wasScaledFor | COVID-19 pandemic NERFINISHED ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: mRNA vaccine Description of subject: An mRNA vaccine is a type of vaccine that uses a small piece of messenger RNA to instruct cells to produce a viral protein, triggering an immune response without using a live virus.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
MRNA